{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:28:01Z","timestamp":1714177681686},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59053","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:36:55Z","timestamp":1714127815000},"source":"Crossref","is-referenced-by-count":0,"title":["Effects of Gap 26, a Connexin 43 Inhibitor, on Cirrhotic Cardiomyopathy in Rats"],"prefix":"10.7759","author":[{"given":"Dlshad","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Khodadoostan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyedeh Elaheh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farahnaz","family":"Jazaeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan D","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008, 371:838-51. 10.1016\/S0140-6736(08)60383-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis EA","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014, 383:1749-61. 10.1016\/S0140-6736(14)60121-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fnetp.2022.849253","article-title":"Pathogenic mechanisms underlying cirrhotic cardiomyopathy","volume":"2","author":"Liu H","year":"2022","unstructured":"Liu H, Nguyen HH, Yoon KT, Lee SS. Pathogenic mechanisms underlying cirrhotic cardiomyopathy. Front Netw Physiol. 2022, 2:849253. 10.3389\/fnetp.2022.849253","journal-title":"Front Netw Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153488","article-title":"Connexin hemichannels and pannexin channels in toxicity: recent advances and mechanistic insights","volume":"488","author":"Yang D","year":"2023","unstructured":"Yang D, Chen M, Yang S, Deng F, Guo X. Connexin hemichannels and pannexin channels in toxicity: recent advances and mechanistic insights. Toxicology. 2023, 488:153488. 10.1016\/j.tox.2023.153488","journal-title":"Toxicology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166258","article-title":"Connexin channels modulation in pathophysiology and treatment of immune and inflammatory disorders","volume":"1867","author":"Tittarelli A","year":"2021","unstructured":"Tittarelli A. Connexin channels modulation in pathophysiology and treatment of immune and inflammatory disorders. Biochim Biophys Acta Mol Basis Dis. 2021, 1867:166258. 10.1016\/j.bbadis.2021.166258","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0840","article-title":"Inhibition of gap junction-mediated intercellular communication by TNF-alpha in cultured human corneal fibroblasts","volume":"46","author":"Hao JL","year":"2005","unstructured":"Hao JL, Suzuki K, Lu Y, et al.. Inhibition of gap junction-mediated intercellular communication by TNF-alpha in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2005, 46:1195-200. 10.1167\/iovs.04-0840","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094413","article-title":"Connexins in the heart: regulation, function and involvement in cardiac disease","volume":"22","author":"Rodr\u00edguez-Sinovas A","year":"2021","unstructured":"Rodr\u00edguez-Sinovas A, S\u00e1nchez JA, Valls-Lacalle L, Consegal M, Ferreira-Gonz\u00e1lez I. Connexins in the heart: regulation, function and involvement in cardiac disease. Int J Mol Sci. 2021, 22:4413. 10.3390\/ijms22094413","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2011.07.039","article-title":"Functional consequences of abnormal Cx43 expression in the heart","volume":"1818","author":"Fontes MS","year":"2012","unstructured":"Fontes MS, van Veen TA, de Bakker JM, van Rijen HV. Functional consequences of abnormal Cx43 expression in the heart. Biochim Biophys Acta. 2012, 1818:2020-9. 10.1016\/j.bbamem.2011.07.039","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-010-0849-6","article-title":"Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury","volume":"460","author":"Hawat G","year":"2010","unstructured":"Hawat G, Benderdour M, Rousseau G, Baroudi G. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury. Pflugers Arch. 2010, 460:583-92. 10.1007\/s00424-010-0849-6","journal-title":"Pflugers Arch"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-804274-8.00040-0","article-title":"Experimental models of liver damage mediated by oxidative stress","author":"Muriel P","year":"2017","unstructured":"Muriel P, Ramos-Tovar E, Montes-P\u00e1ez G, Buend\u00eda-Monta\u00f1o LD. Experimental models of liver damage mediated by oxidative stress. Liver Pathophysiology. Muriel P (ed): Academic Press, London, United Kingdom; 2017. 529-46. 10.1016\/B978-0-12-804274-8.00040-0"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/cac.10.4-6.251.257","article-title":"Connexin channels, connexin mimetic peptides and ATP release","volume":"10","author":"Leybaert L","year":"2003","unstructured":"Leybaert L, Braet K, Vandamme W, Cabooter L, Martin PE, Evans WH. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes. 2003, 10:251-7. 10.1080\/cac.10.4-6.251.257","journal-title":"Cell Commun Adhes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.86064","article-title":"Histopathological and biochemical assessment of liver damage in albino Wistar rats treated with cytotoxic platinum compounds in combination with 5-fluorouracil","volume":"15","author":"Bano N","year":"2019","unstructured":"Bano N, Najam R. Histopathological and biochemical assessment of liver damage in albino Wistar rats treated with cytotoxic platinum compounds in combination with 5-fluorouracil. Arch Med Sci. 2019, 15:1092-103. 10.5114\/aoms.2019.86064","journal-title":"Arch Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12039","article-title":"Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats","volume":"33","author":"Jazaeri F","year":"2013","unstructured":"Jazaeri F, Tavangar SM, Ghazi-Khansari M, Khorramizadeh MR, Mani AR, Dehpour AR. Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats. Liver Int. 2013, 33:368-74. 10.1111\/liv.12039","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120966","article-title":"Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats","volume":"308","author":"Niaz Q","year":"2022","unstructured":"Niaz Q, Tavangar SM, Mehreen S, Ghazi-Khansari M, Jazaeri F. Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats. Life Sci. 2022, 308:120966. 10.1016\/j.lfs.2022.120966","journal-title":"Life Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119261","article-title":"Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats","volume":"273","author":"Esmaeili Z","year":"2021","unstructured":"Esmaeili Z, Niaz Q, Saffari PM, Dehpour AR, Rezayat SM, Jazaeri F. Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats. Life Sci. 2021, 273:119261. 10.1016\/j.lfs.2021.119261","journal-title":"Life Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege JA","year":"1978","unstructured":"Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-10. 10.1016\/s0076-6879(78)52032-6","journal-title":"Methods Enzymol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121285","article-title":"What's new in cirrhotic cardiomyopathy?-review article","volume":"11","author":"Bodys-Pe\u0142ka A","year":"2021","unstructured":"Bodys-Pe\u0142ka A, Kusztal M, Raszeja-Wyszomirska J, G\u0142\u00f3wczy\u0144ska R, Grabowski M. What's new in cirrhotic cardiomyopathy?-review article. J Pers Med. 2021, 11:1285. 10.3390\/jpm11121285","journal-title":"J Pers Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats","volume":"130","author":"Hennenberg M","year":"2006","unstructured":"Hennenberg M, Biecker E, Trebicka J, et al.. Defective RhoA\/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology. 2006, 130:838-54. 10.1053\/j.gastro.2005.11.029","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2013.06.002","article-title":"Heart failure in patients with liver cirrhosis","volume":"55","author":"Pudil R","year":"2013","unstructured":"Pudil R, Pelouch R, Praus R, Va\u0161atov\u00e1 M, H\u016flek P. Heart failure in patients with liver cirrhosis. Cor et Vasa. 2013, 55:e391-6. 10.1016\/j.crvasa.2013.06.002","journal-title":"Cor et Vasa"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3601","article-title":"Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C\/VEGFR-3 signaling pathway","volume":"12","author":"Du HT","year":"2016","unstructured":"Du HT, Liu P. Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C\/VEGFR-3 signaling pathway. Exp Ther Med. 2016, 12:2120-8. 10.3892\/etm.2016.3601","journal-title":"Exp Ther Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-017-0207-8","article-title":"Corneal cross-linking has no effect on matrix metalloproteinase 9 and 13 levels during fungal keratitis on the early stage","volume":"183","author":"Kalkanci A","year":"2018","unstructured":"Kalkanci A, Bilgihan K, Ozdemir HB, Yar Saglam AS, Karakurt F, Erdogan M. Corneal cross-linking has no effect on matrix metalloproteinase 9 and 13 levels during fungal keratitis on the early stage. Mycopathologia. 2018, 183:329-36. 10.1007\/s11046-017-0207-8","journal-title":"Mycopathologia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1998-y","article-title":"Inhibition of gap junction composed of Cx43 prevents against acute kidney injury following liver transplantation","volume":"10","author":"Yuan D","year":"2019","unstructured":"Yuan D, Li X, Luo C, et al.. Inhibition of gap junction composed of Cx43 prevents against acute kidney injury following liver transplantation. Cell Death Dis. 2019, 10:767. 10.1038\/s41419-019-1998-y","journal-title":"Cell Death Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096043","article-title":"Pathological changes in pulmonary circulation in carbon tetrachloride (CCl4)-induced cirrhotic mice","volume":"9","author":"Das M","year":"2014","unstructured":"Das M, Boerma M, Goree JR, et al.. Pathological changes in pulmonary circulation in carbon tetrachloride (CCl4)-induced cirrhotic mice. PLoS One. 2014, 9:e96043. 10.1371\/journal.pone.0096043","journal-title":"PLoS One"},{"key":"ref24","article-title":"Prolongation of the QTc interval in patients with cirrhosis","volume":"16","author":"Mimidis K","year":"2003","unstructured":"Mimidis K, Papadopoulos V, Thomopoulos K, et al.. Prolongation of the QTc interval in patients with cirrhosis. Ann Gastroenterol. 2003, 16:155-8.","journal-title":"Ann Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids - clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan T","year":"2018","unstructured":"Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik J, Williamson C. Heart and bile acids - clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018, 1864:1345-55. 10.1016\/j.bbadis.2017.12.039","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.10.030","article-title":"Role of connexin 43 in cardiovascular diseases","volume":"768","author":"Michela P","year":"2015","unstructured":"Michela P, Velia V, Aldo P, Ada P. Role of connexin 43 in cardiovascular diseases. Eur J Pharmacol. 2015, 768:71-6. 10.1016\/j.ejphar.2015.10.030","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2946-0_3","article-title":"Intracellular calcium and myocardial function during ischemia","volume":"346","author":"Allen DG","year":"1993","unstructured":"Allen DG, Cairns SP, Turvey SE, Lee JA. Intracellular calcium and myocardial function during ischemia. Adv Exp Med Biol. 1993, 346:19-29. 10.1007\/978-1-4615-2946-0_3","journal-title":"Adv Exp Med Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.11.048","article-title":"The molecular mechanisms of gap junction remodeling","volume":"9","author":"Duffy HS","year":"2012","unstructured":"Duffy HS. The molecular mechanisms of gap junction remodeling. Heart Rhythm. 2012, 9:1331-4. 10.1016\/j.hrthm.2011.11.048","journal-title":"Heart Rhythm"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.19082\/1984","article-title":"Brain natriuretic peptide in liver cirrhosis and fatty liver: correlation with cardiac performance","volume":"8","author":"Metwaly A","year":"2016","unstructured":"Metwaly A, Khalik AA, Nasr FM, Sabry AI, Gouda MF, Hassan M. Brain natriuretic peptide in liver cirrhosis and fatty liver: correlation with cardiac performance. Electron Physician. 2016, 8:1984-93. 10.19082\/1984","journal-title":"Electron Physician"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4318\/tjg.2010.0124","article-title":"Relationship of increased serum brain natriuretic peptide levels with hepatic failure, portal hypertension and treatment in patients with cirrhosis","volume":"21","author":"Yilmaz VT","year":"2010","unstructured":"Yilmaz VT, Eken C, Avci AB, Duman A, Tuna Y, Akin M, Yildirim B. Relationship of increased serum brain natriuretic peptide levels with hepatic failure, portal hypertension and treatment in patients with cirrhosis. Turk J Gastroenterol. 2010, 21:381-6. 10.4318\/tjg.2010.0124","journal-title":"Turk J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9343","article-title":"Therapeutic effect of chitosan on CCl4\u2011induced hepatic fibrosis in rats","volume":"18","author":"Wang ZF","year":"2018","unstructured":"Wang ZF, Wang MY, Yu DH, et al.. Therapeutic effect of chitosan on CCl4\u2011induced hepatic fibrosis in rats. Mol Med Rep. 2018, 18:3211-8. 10.3892\/mmr.2018.9343","journal-title":"Mol Med Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.05.011","article-title":"Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels","volume":"47","author":"Smith BD","year":"2014","unstructured":"Smith BD, Yartel AK. Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. Am J Prev Med. 2014, 47:233-41. 10.1016\/j.amepre.2014.05.011","journal-title":"Am J Prev Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12352","article-title":"Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis","volume":"38","author":"Hoofnagle JH","year":"2013","unstructured":"Hoofnagle JH, Van Natta ML, Kleiner DE, et al.. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2013, 38:134-43. 10.1111\/apt.12352","journal-title":"Aliment Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo PY","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017, 112:18-35. 10.1038\/ajg.2016.517","journal-title":"Am J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1958.00030010405009","article-title":"A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis","volume":"102","author":"Lunseth JH","year":"1958","unstructured":"Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med. 1958, 102:405-13. 10.1001\/archinte.1958.00030010405009","journal-title":"AMA Arch Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6106","article-title":"TNF\u2011\u03b1 regulates apoptosis of human vascular smooth muscle cells through gap junctions","volume":"15","author":"Tang M","year":"2017","unstructured":"Tang M, Fang J. TNF\u2011\u03b1 regulates apoptosis of human vascular smooth muscle cells through gap junctions. Mol Med Rep. 2017, 15:1407-11. 10.3892\/mmr.2017.6106","journal-title":"Mol Med Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04063.x","article-title":"Nitric oxide transport and storage in the cardiovascular system","volume":"962","author":"Muller B","year":"2002","unstructured":"Muller B, Kleschyov AL, Alencar JL, Vanin A, Stoclet JC. Nitric oxide transport and storage in the cardiovascular system. Ann N Y Acad Sci. 2002, 962:131-9. 10.1111\/j.1749-6632.2002.tb04063.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8050052","article-title":"Peptidic connexin43 therapeutics in cardiac reparative medicine","volume":"8","author":"Marsh SR","year":"2021","unstructured":"Marsh SR, Williams ZJ, Pridham KJ, Gourdie RG. Peptidic connexin43 therapeutics in cardiac reparative medicine. J Cardiovasc Dev Dis. 2021, 8:52. 10.3390\/jcdd8050052","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00722","article-title":"The dark side of Nrf2 in the heart","volume":"11","author":"Zang H","year":"2020","unstructured":"Zang H, Mathew RO, Cui T. The dark side of Nrf2 in the heart. Front Physiol. 2020, 11:722. 10.3389\/fphys.2020.00722","journal-title":"Front Physiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000872","article-title":"Protective effects of spermidine against cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"76","author":"Sheibani M","year":"2020","unstructured":"Sheibani M, Nezamoleslami S, Mousavi SE, Faghir-Ghanesefat H, Yousefi-Manesh H, Rezayat SM, Dehpour A. Protective effects of spermidine against cirrhotic cardiomyopathy in bile duct-ligated rats. J Cardiovasc Pharmacol. 2020, 76:286-95. 10.1097\/FJC.0000000000000872","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1036-y","article-title":"Inhibition of connexin 43 attenuates oxidative stress and apoptosis in human umbilical vein endothelial cells","volume":"20","author":"Ma JW","year":"2020","unstructured":"Ma JW, Ji DD, Li QQ, Zhang T, Luo L. Inhibition of connexin 43 attenuates oxidative stress and apoptosis in human umbilical vein endothelial cells. BMC Pulm Med. 2020, 20:19. 10.1186\/s12890-019-1036-y","journal-title":"BMC Pulm Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5772\/46180","article-title":"Lipid peroxidation in hepatic fibrosis","author":"Shimizu I","year":"2012","unstructured":"Shimizu I, Shimamoto N, Saiki K, Furujo M, Osaw K. Lipid peroxidation in hepatic fibrosis. Lipid Peroxidation. Catala A (ed): IntechOpen, London, United Kingdom; 2012. 483-92. 10.5772\/46180"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4137\/bmi.s639","article-title":"Serum and ascitic fluid superoxide dismutase and malondialdehyde levels in patients with cirrhosis","volume":"3","author":"Ozenirler S","year":"2008","unstructured":"Ozenirler S, Sancak B, Coskun U. Serum and ascitic fluid superoxide dismutase and malondialdehyde levels in patients with cirrhosis. Biomark Insights. 2008, 3:141-5. 10.4137\/bmi.s639","journal-title":"Biomark Insights"},{"key":"ref44","article-title":"Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients","volume":"8","author":"Wang SL","year":"2015","unstructured":"Wang SL, Zhu XY, Zhang DW, Zhang ZJ, Gao HJ, Yang CQ. Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients. Int J Clin Exp Med. 2015, 8:11007-13.","journal-title":"Int J Clin Exp Med"},{"key":"ref45","article-title":"Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients","volume":"8","author":"Wang SL","year":"2015","unstructured":"Wang SL, Zhu XY, Zhang DW, Zhang ZJ, Gao HJ, Yang CQ. Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients. Int J Clin Exp Med. 2015, 8:11007-13.","journal-title":"Int J Clin Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238119-effects-of-gap-26-a-connexin-43-inhibitor-on-cirrhotic-cardiomyopathy-in-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:37:00Z","timestamp":1714127820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238119-effects-of-gap-26-a-connexin-43-inhibitor-on-cirrhotic-cardiomyopathy-in-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.59053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}